Senior Staff Scientist
JP Gonzalez graduated from the Medical School of Bordeaux in 1974 (France), completed his internship in French Guyana at the University Hospital Center of Antilles-Guyana (internal medicine and infectious diseases), and received his Ph.D.
in viral ecology (Arenavirus molecular ecology) in 1984 from Clermont-Ferrand University (France). He went on to study zoology, marine biology and genetics at Bordeaux University Faculty of Sciences, and got his Master of Public Health &
Tropical Medicine form the Medical School of Bordeaux (1975)
As a medical researcher and formerly Research Director for the French Institute of Research for Development (IRD, Marseille, France), he has spent his career working in and for developing countries of South America, Africa and Asia (1979-2012).
His main fields of interest encompass viral disease epidemiology, virus ecology, arboviruses and viral hemorrhagic fevers and understanding fundamentals of disease emergence. Since the late 70s, he has led international teams with partner
institutions of developing countries as well as teams of virologists at the International Network of the Institut Pasteur (Dakar, Senegal; Bangui, Central African Republic). He worked for several years as a guest researcher at the Special
Pathogen Branch of the Centers for Disease Control and Prevention (CDC) in Atlanta (Georgia, USA), visiting scientist at the Arbovirus branch of CDC in Fort Collins, and as a visiting professor of Epidemiology and Public Health at the Yale
School of Medicine (New England, USA). He worked in high security laboratory practices and research (CDC, Yale) and on the early development of geographical information systems applied to Public Health and Infectious Diseases (Yale). From
1997 to 2007, he was invited as a visiting professor of Microbiology, Mahidol University (Thailand) where he founded the Research Center for Emerging Viral Diseases and developed a Technical Platform for the study of Emerging Vector Borne
Diseases. He largely contributed to the development of tools and implemented strategies for the control and prevention of transmitted disease. He also developed several innovative concepts including the evolution of viruses on the geological
time scale, the co-evolution as a general mode of evolution among others.
Country Director, Metabiota Inc.-Global Virus Forecasting (2011-Present).
M & E. Consultant to Global Fund for TB, (April 2010-April 2011).
Vice Chancellor & Principal, University of Sierra Leone (2005-2009)
Professor of Microbiology, College of Medicine and Allied Health Sciences, University of Sierra Leone (2005-2009).
Associate Professor, Biology Department, Morgan State University, Baltimore, Maryland (1997-2005).
Member, MPH Integrated Experience Panel, School of Hygiene and Public Health, Johns Hopkins University (1998-2002).
Senior Fulbright Research Fellow, 1991-1993, Department of Molecular Microbiology and Immunology, Bloomberg School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD.
Visiting Scholar (1994-1997), Department of Molecular Microbiology and Immunology, Bloomberg School of Hygiene and Public Health, Johns Hopkins
University, Baltimore, Maryland.
I mainly direct the activities of Metabiota Inc. in country. Initially, our work involves research and the control of Lassa fever in the laboratory, clinical aspects the impact of climate and environmental changes of the population of Mastymus,
reservoir of the Lassa virus.
With the advent of the ebola outbreak, our activities now address the containment of the outbreak in the country. My main role is coordination of ebola containment activities. I am based in Freetown, the capital of Sierra Leone but do make
visits to the field to monitor case management, contact tracing and addressing issues relevant to the outbreak by our consultants in the field. 2
Our major challenges remain the denial by most of the population, limited supplies of PPEs, gloves, face masks, aprons, thermometers etc. The most pressing challenges are the lack of medical personnel to work in the treatment centers
and to therefore
Chief Representative, China
Neal Liang is characteristically experienced in biochemical and cell biological research. In Metabiota Inc., Neal works at the Guangzhou Representative Office as the Chief Representative, fully accounting for the Office’s operation, supervising
all programs implementation in China towards their sustainable development, and serving a lead role in future extension through coordinated efforts with HQ. In addition to roles in scientific and operational functions, he also participates
Metabiota’s commercialized product/service development as well as its future market assessment and sales in China.
Neal received his doctorate degree in Biochemistry from The Chinese University of Hong Kong, Hong Kong. With extensive knowledge in biochemical sciences, he is currently managing USAID funded infectious disease research programs that adopts
multiple laboratory analysis methods.